| Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT) (NCT02594072) | University of British Columbia | 2016-04-01 |
| Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer. (NCT02745587) | University Hospital, Ghent | 2016-04-01 |
| Integrated 18F-labelled PSMA Project (NCT02691169) | St. Joseph's Healthcare Hamilton | 2016-04-01 |
| Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study (NCT02786459) | University Health Network, Toronto | 2016-04-01 |
| Sulphate Accumulation in Prostate (NCT02821728) | Quadram Institute Bioscience | 2016-04-01 |
| CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr (NCT02689271) | University College, London | 2016-04-01 |
| Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization (NCT03440554) | University of California, San Diego | 2016-03-24 |
| Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer (NCT02526368) | Ivan de Kouchkovsky, MD | 2016-03-22 |
| A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02737332) | Sun Pharmaceutical Industries Limited | 2016-03-21 |
| Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 (NCT02601014) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-03-15 |
| Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer (NCT03744494) | University College Hospital, Ibadan | 2016-03-02 |
| Study of MR-based IGRT for Prostate Cancer (NCT02724670) | University Hospital Tuebingen | 2016-03-01 |
| Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer (NCT02723526) | Fudan University | 2016-03-01 |
| ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes (NCT02840617) | Third Affiliated Hospital, Sun Yat-Sen University | 2016-03-01 |
| Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program (NCT02585362) | Kantonsspital Winterthur KSW | 2016-03-01 |
| True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners (NCT02702453) | University of Michigan | 2016-03-01 |
| Asia Study Group of Prostate Cancer (A-CaP Study) (NCT02873013) | Japan Study Group of Prostate Cancer | 2016-03-01 |
| Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT) (NCT02724618) | Shahid Beheshti University of Medical Sciences | 2016-03-01 |
| Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate (NCT02882958) | Massachusetts General Hospital | 2016-03-01 |
| The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy (NCT02573636) | Sir Mortimer B. Davis - Jewish General Hospital | 2016-03-01 |
| Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate (NCT02822963) | National Cheng-Kung University Hospital | 2016-03-01 |
| SBRT for Oligometastatic Castration-Refractory Prostate Cancer (NCT02816983) | Mayo Clinic | 2016-03-01 |
| Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases (NCT02758132) | University of Hawaii | 2016-03-01 |
| Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation? (NCT02759380) | Sahlgrenska University Hospital | 2016-03-01 |
| Preoperative Brimonidine on IOP of Patients Undergoing RALP (NCT02818816) | University Health Network, Toronto | 2016-02-29 |
| A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer (NCT02499497) | Dana-Farber Cancer Institute | 2016-02-29 |
| Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate Cancer (NCT03100981) | University of Aarhus | 2016-02-24 |
| Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC (NCT02463799) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-02-22 |
| Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients (NCT03524391) | NMP Medical Research Institute | 2016-02-12 |
| Neoadjuvant J591 Treatment for Prostate Cancer (NCT02693860) | Weill Medical College of Cornell University | 2016-02-04 |
| Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer (NCT02618200) | Hospices Civils de Lyon | 2016-02-01 |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors (NCT02957357) | Alliance Foundation Trials, LLC. | 2016-02-01 |
| Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (NCT02397317) | University of Sydney | 2016-02-01 |
| Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer (NCT02685267) | Prostate Cancer Clinical Trials Consortium | 2016-02-01 |
| Robotic Surgery After Focal Ablation Therapy (NCT03011606) | Queen Mary University of London | 2016-02-01 |
| Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer (NCT02572284) | H. Lee Moffitt Cancer Center and Research Institute | 2016-01-27 |
| Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate (NCT03853902) | Northwestern University | 2016-01-26 |
| Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer (NCT02649855) | National Cancer Institute (NCI) | 2016-01-19 |
| SPORT High-Risk Trial Evaluating SABR in Prostate Cancer (NCT03253978) | Belfast Health and Social Care Trust | 2016-01-18 |
| Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer (NCT02821793) | Institut Bergonié | 2016-01-01 |
| Hong Kong Prostate Cancer Study Group Database (NCT03344835) | Chinese University of Hong Kong | 2016-01-01 |
| PET/MRI in Patients With Suspected Prostate Cancer (NCT02659527) | Medical University of Vienna | 2016-01-01 |
| Reducing Dexamethasone Around Docetaxel Infusion (NCT02776436) | Leiden University Medical Center | 2016-01-01 |
| Predictors of Nodal and Distant Metastatic Disease Detected by PSMA PET in Treatment-Naïve High-Risk Prostate Cancer: A Czech Multicentre Cohort Study (NCT07608419) | General University Hospital, Prague | 2016-01-01 |
| Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study (NCT02895230) | Rennes University Hospital | 2016-01-01 |
| Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGO (NCT04516707) | Institut du Cancer de Montpellier - Val d'Aurelle | 2016-01-01 |
| Abiraterone-Rechallenge Study for CRPC Patients (NCT02656615) | Aurelius Omlin | 2016-01-01 |
| Prostvac in Patients With Biochemically Recurrent Prostate Cancer (NCT02649439) | National Cancer Institute (NCI) | 2015-12-22 |
| Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue (NCT02594202) | National Cancer Institute (NCI) | 2015-12-21 |
| Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients (NCT02611882) | Thomas Hope | 2015-12-18 |
| Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery (NCT02706561) | Memorial Sloan Kettering Cancer Center | 2015-12-08 |
| CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer (NCT02831920) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-12-07 |
| Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer (NCT02648919) | University of Hawaii | 2015-12-01 |
| Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy (NCT02488096) | Saskatchewan Health Authority - Regina Area | 2015-12-01 |
| Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer (NCT02615067) | Molecular Insight Pharmaceuticals, Inc. | 2015-12-01 |
| Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease (NCT02678832) | Heidelberg University | 2015-12-01 |
| Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients (NCT02678520) | University of Kansas Medical Center | 2015-12-01 |
| Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability (NCT02663193) | Janssen Scientific Affairs, LLC | 2015-12-01 |
| A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer (NCT02526784) | Ferring Pharmaceuticals | 2015-12-01 |
| Biparametric MRI for Detection of Significant Prostate Cancer (NCT02584179) | Herlev Hospital | 2015-12-01 |
| Hypofractionated Radiosurgery for Localised Prostate Cancer (NCT02635256) | University Hospital Schleswig-Holstein | 2015-12-01 |
| The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient (NCT02588404) | Sir Mortimer B. Davis - Jewish General Hospital | 2015-12-01 |
| A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC (NCT02489318) | Aragon Pharmaceuticals, Inc. | 2015-11-27 |
| LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC (NCT02494921) | Rahul Aggarwal | 2015-11-20 |
| Investigating Mindfulness and Music to Ease Radiation Side Effects in Prostate Cancer (NCT03852017) | Northwestern University | 2015-11-11 |
| Body Composition and White Adipose Tissue Inflammation (NCT02713022) | Memorial Sloan Kettering Cancer Center | 2015-11-04 |
| Prostate Biopsy Access Needle & Needle Guide Feasibility Study (NCT02828839) | Perineologic | 2015-11-01 |
| Salvage Radiotherapy After Radical Prostatectomy (NCT02597725) | University of Aarhus | 2015-11-01 |
| Collaborative Network to Take Responsibility for Oral Anticancer Therapy (NCT02861209) | KU Leuven | 2015-11-01 |
| 68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated (NCT02920229) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2015-11-01 |
| A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer (NCT02623647) | Regina Elena Cancer Institute | 2015-11-01 |
| Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy (NCT03982706) | Rabin Medical Center | 2015-10-28 |
| 11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients. (NCT06179706) | IRCCS San Raffaele | 2015-10-27 |
| A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (NCT03127631) | McMaster University | 2015-10-21 |
| The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. (NCT05097274) | Institute of Cancer Research, United Kingdom | 2015-10-15 |
| Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes? (NCT06170164) | IRCCS San Raffaele | 2015-10-08 |
| The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population (NCT03893929) | Chinese University of Hong Kong | 2015-10-07 |
| MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca (NCT02564549) | Virginia Commonwealth University | 2015-10-05 |
| Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours (NCT02804815) | University College, London | 2015-10-01 |
| Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté (NCT02626377) | Centre Hospitalier Universitaire de Besancon | 2015-10-01 |
| Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide (NCT02588001) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2015-10-01 |
| HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer (NCT02628041) | CHU de Quebec-Universite Laval | 2015-10-01 |
| Phase III Radium 223 mCRPC-PEACE III (NCT02194842) | European Organisation for Research and Treatment of Cancer - EORTC | 2015-10-01 |
| Functional Medical Imaging Quantization in Prostate Cancer (NCT03376360) | University Hospital, Brest | 2015-10-01 |
| Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer (NCT02494713) | The University of Texas Health Science Center, Houston | 2015-10-01 |
| Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer (NCT02353819) | University of Texas Southwestern Medical Center | 2015-10-01 |
| Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone. (NCT02630641) | Ipsen | 2015-10-01 |
| Decipher Genomics Resource for Intelligent Discovery (NCT02609269) | GenomeDx Biosciences Corp | 2015-10-01 |
| Radium 223 Following Intermittent ADT (NCT02656563) | Canadian Urology Research Consortium | 2015-10-01 |
| Understanding the Value of Community Vital Signs in Primary Care (NCT02512835) | Virginia Commonwealth University | 2015-10-01 |
| Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients (NCT04340024) | National Cancer Centre, Singapore | 2015-09-30 |
| MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients (NCT02623933) | Sunnybrook Health Sciences Centre | 2015-09-24 |
| 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer (NCT02559115) | Memorial Sloan Kettering Cancer Center | 2015-09-21 |
| Focal Laser Ablation of Prostate Tissue (NCT02357121) | Jonsson Comprehensive Cancer Center | 2015-09-17 |
| Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC (NCT02577627) | Optimata Ltd. | 2015-09-01 |
| Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate Cancer (NCT03615131) | Kantonsspital Winterthur KSW | 2015-09-01 |
| Hemiablative Focal Brachytherapy Pilot Study (NCT02643511) | St George Hospital, Australia | 2015-09-01 |
| Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy (NCT02620033) | The University of Texas Health Science Center at San Antonio | 2015-09-01 |
| Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device (NCT02524860) | Focal Healthcare Inc. | 2015-09-01 |
| Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal (NCT02534376) | Cedars-Sinai Medical Center | 2015-09-01 |